TNF receptor independent activation of the cytomegalovirus major immediate early enhancer in response to transplantation

Transplantation

Volumn 85, Issue 7, 2008, Pages 1039-1045

  Zhang, Zheng ^a   Kim, Soo Jung ^a,b   Varghese, Thomas ^c   Thomas, Gail ^a   Hummel, Mary ^a   Abecassis, Michael ^a,d  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Rosalind Franklin Institute   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d NORTHWESTERN MEMORIAL HOSPITAL   (United States)

Author keywords

Cytomegalovirus; Latency; Reactivation; TNF

Indexed keywords

BETA GALACTOSIDASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR FRA 1; TRANSCRIPTION FACTOR JUND; TUMOR NECROSIS FACTOR RECEPTOR;

ALLOGRAFT; ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN CYTOMEGALOVIRUS; IMMEDIATE EARLY GENE; ISOGRAFT; KIDNEY TRANSPLANTATION; LATENT VIRUS INFECTION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RENAL GRAFT DYSFUNCTION; RISK FACTOR; VIRUS REACTIVATION;

ANIMALS; BETA-GALACTOSIDASE; CYTOMEGALOVIRUS; ENHANCER ELEMENTS (GENETICS); KIDNEY; KIDNEY TRANSPLANTATION; MICE; MICE, KNOCKOUT; NF-KAPPA B; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SIGNAL TRANSDUCTION; TRANSPLANTATION, HOMOLOGOUS; VIRUS ACTIVATION;

EID: 42149111590     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318168449c     Document Type: Article

References (54)

1. Razonable RR, Paya CV. Beta-herpesviruses in transplantation. Reviews in Medical. Microbiology 2002; 13: 163.
2. Mocarski ES, Courcell CT. Cytomegaloviruses and their replication. In: Knipe DM, Howley PM, eds. Fields virology, vol. 2. Philadelphia, Lippincott Williams & Wilkins 2001, p 2629.
3. Meier JL, Stinski MF. Major immediate-early enhancer and its gene products. In: Reddehase MJ, ed. Cytomegaloviruses molecular biology and immunology. Norfolk, UK, Caister Academic Press 2006, pp 151-166.
4. Gawn JM, Greaves RF. Absence of IE1 p72 protein function during low-multiplicity infection by human cytomegalovirus results in a broad block to viral delayed-early gene expression. J Virol 2002; 76: 4441.
5. Greaves RF, Mocarski ES. Defective growth correlates with reduced accumulation of a viral DNA replication protein after low-multiplicity infection by a human cytomegalovirus ie1 mutant. J Virol 1998; 72: 366.
6. Marchini A, Liu H, Zhu H. Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes. J Virol 2001; 75: 1870.
7. Mocarski ES, Kemble GW, Lyle JM, et al. A deletion mutant in the human cytomegalovirus gene encoding IE1(491aa) is replication defective due to a failure in autoregulation. Proc Natl Acad Sci USA 1996; 93: 11321.
8. Reeves MB, MacAry PA, Lehner PJ, et al. Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proc Natl Acad Sci USA 2005; 102: 4140.
9. Taylor-Wiedeman J, Sissons P, Sinclair J. Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers. J Virol 1994; 68: 1597.
10. Kurz SK, Reddehase MJ. Patchwork pattern of transcriptional reactivation in the lungs indicates sequential checkpoints in the transition from murine cytomegalovirus latency to recurrence. J Virol 1999; 73: 8612.
11. Hummel M, Zhang Z, Yan S, et al. Allogeneic transplantation induces expression of cytomegalovirus immediate-early genes in vivo: A model for reactivation from latency. J Virol 2001; 75: 4814.
12. Meier JL, Stinski MF. Regulation of human cytomegalovirus immediate-early gene expression. Intervirology 1996; 39: 331.
13. Prosch S, Staak K, Stein J, et al. Stimulation of the human cytomegalovirus IE enhancer/promoter in HL-60 cells by TNF alpha is mediated via induction of NF-kB. Virology 1995; 208: 197.
14. Stein J, Volk HD, Liebenthal C, et al. Tumor necrosis factor alpha stimulates the activity of the human cytomegalovirus major immediate early enhancer/promoter in immature monocytic cells. J Gen Virol 1993; 74(Pt 11): 2333.
15. Mutimer D, Mirza D, Shaw J, et al. Enhanced (cytomegalovirus) viral replication associated with septic bacterial complications in liver transplant recipients. Transplantation 1997; 63: 1411.
16. Fietze E, Prosch S, Reinke P, et al. Cytomegalovirus infection in transplant recipients. The role of tumor necrosis factor. Transplantation 1994; 58: 675.
17. Hibberd PL, Tolkoff-Rubin NE, Cosimi AB, et al. Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3. Transplantation 1992; 53: 68.
18. Portela D, Patel R, Larson-Keller JJ, et al. OKT3 treatment for allograft rejection is a risk factor for cytomegalovirus disease in liver transplantation. J Infect Dis 1995; 171: 1014.
19. Docke WD, Prosch S, Fietze E, et al. Cytomegalovirus reactivation and tumor necrosis factor. Lancet 1994; 343: 268.
20. Heininger A, Jahn G, Engel C, et al. Human cytomegalovirus infections in nonimmunosuppressed critically ill patients [see comments]. Crit Care Med 2001; 29: 541.
21. Kutza AS, Muhl E, Hackstein H, et al. High incidence of active cytomegalovirus infection among septic patients [see comments]. Clin Infect Dis 1998; 26: 1076.
22. Baskar JF, Smith PP, Nilaver G, et al. The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice. J Virol 1996; 70: 3207.
23. Kim SJ, Varghese TK, Zhang Z, et al. Renal ischemia/reperfusion injury activates the enhancer domain of the human cytomegalovirus major immediate early promoter. Am J Transplant 2005; 5: 1606.
24. Zhang Z, Schlachta C, Duff J, et al. Improved techniques for kidney transplantation in mice. Microsurgery 1995; 16: 103.
25. Baud V, Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 2001; 11: 372.
26. Pfeffer K, Matsuyama T, Kundig TM, et al. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 1993; 73: 457.
27. Erickson SL, de Sauvage FJ, Kikly K, et al. Decreased sensitivity to tumor-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature 1994; 372: 560.
28. Grell M, Douni E, Wajant H, et al. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 1995; 83: 793.
29. Boshart M, Weber F, Jahn G, et al. A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 1985; 41: 521.
30. Cherrington JM, Mocarski ES. Human cytomegalovirus ie1 transactivates the alpha promoter-enhancer via an 18-base-pair repeat element. J Virol 1989; 63: 1435.
31. DeMeritt IB, Milford LE, Yurochko AD. Activation of the NF-kappaB pathway in human cytomegalovirus-infected cells is necessary for efficient transactivation of the major immediate-early promoter. J Virol 2004; 78: 4498.
32. Hunninghake GW, Monick MM, Liu B, et al. The promoter-regulatory region of the major immediate-early gene of human cytomegalovirus responds to T-lymphocyte stimulation and contains functional cyclic AMP-response elements. J Virol 1989; 63: 3026.
33. Lee Y, Sohn WJ, Kim DS, et al. NF-kappaB- and c-Jun-dependent regulation of human cytomegalovirus immediate-early gene enhancer/promoter in response to lipopolysaccharide and bacterial CpG-oligodeoxynucleotides in macrophage cell line RAW 264.7. Eur J Biochem 2004; 271: 1094.
34. Liu B, Stinski MF. Human cytomegalovirus contains a tegument protein that enhances transcription from promoters with upstream ATF and AP-1 cis-acting elements. J Virol 1992; 66: 4434.
35. Sambucetti LC, Cherrington JM, Wilkinson GW, et al. NF-kappa B activation of the cytomegalovirus enhancer is mediated by a viral trans-activator and by T cell stimulation. EMBO J 1989; 8: 4251.
36. Stinski MF, Roehr TJ. Activation of the major immediate early gene of human cytomegalovirus by cis-acting elements in the promoter-regulatory sequence and by virus-specific trans-acting components. J Virol 1985; 55: 431.
37. Karin M, Shaulian E. AP-1: linking hydrogen peroxide and oxidative stress to the control of cell proliferation and death. IUBMB Life 2001; 52: 17.
38. Kyriakis JM. Activation of the AP-1 transcription factor by inflammatory cytokines of the TNF family. Gene Expr 1999; 7: 217.
39. Isomura H, Stinski MF, Kudoh A, et al. Two Sp1/Sp3 binding sites in the major immediate-early proximal enhancer of human cytomegalovirus have a significant role in viral replication. J Virol 2005; 79: 9597.
40. Keller MJ, Wu AW, Andrews JI, et al. Reversal of human cytomegalovirus major immediate-early enhancer/promoter silencing in quiescently infected cells via the cyclic AMP signaling pathway. J Virol 2007; 81: 6669.
41. Mayr B, Montminy M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2001; 2: 599.
42. Razonable RR, Paya CV. Herpesvirus infections in transplant recipients: Current challenges in the clinical management of cytomegalovirus and Epstein-Barr virus infections. Herpes 2003; 10: 60.
43. Prosch S, Volk H-D, Reinke P, et al. Human cytomegalovirus infection in transplant recipients: Role of TNF-alpha for reactivation and replication of human cytomegalovirus. In: Scholz M, Rabenau HF, Doerr HW, Cinatl J, eds. CMV-related immunopathology, vol 21. Basel, Karger 1998, p 29.
44. Famulski KS, Einecke G, Reeve J, et al. Changes in the transcriptome in allograft rejection: IFN-gamma-induced transcripts in mouse kidney allografts. Am J Transplant 2006; 6: 1342.
45. Barnes PJ, Karin M. Nuclear factor-kappaB: A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336: 1066.
46. Karin M, Liu Z, Zandi E. AP-1 function and regulation. Curr Opin Cell Biol 1997; 9: 240.
47. Gerald D, Berra E, Frapart YM, et al. JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell 2004; 118: 781.
48. Chen H, Pan YX, Dudenhausen EE, et al. Amino acid deprivation induces the transcription rate of the human asparagine synthetase gene through a timed program of expression and promoter binding of nutrient-responsive basic region/leucine zipper transcription factors as well as localized histone acetylation. J Biol Chem 2004; 279: 50829.
49. Hai TW, Liu F, Allegretto EA, et al. A family of immunologically related transcription factors that includes multiple forms of ATF and AP-1. Genes Dev 1988; 2: 1216.
50. Harding HP, Zhang Y, Zeng H, et al. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol Cell 2003; 11: 619.
51. Liang G, Audas TE, Li Y, et al. Luman/CREB3 induces transcription of the endoplasmic reticulum (ER) stress response protein Herp through an ER stress response element. Mol Cell Biol 2006; 26: 7999.
52. Hayry P, Lemstrom K, von Willebrand E, et al. CMV infection and allograft rejection. Transplant Proc 1998; 30: 916.
53. Gustems M, Borst E, Benedict CA, et al. Regulation of the transcription and replication cycle of human cytomegalovirus is insensitive to genetic elimination of the cognate NF-kappaB binding sites in the enhancer. J Virol 2006; 80: 9899.
54. Keller MJ, Wheeler DG, Cooper E, et al. Role of the human cytomegalovirus major immediate-early promoter's 19-base-pair-repeat cyclic AMP-response element in acutely infected cells. J Virol 2003; 77: 6666.